These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11236957)

  • 81. Telomerase and human papillomavirus as diagnostic adjuncts for cervical dysplasia and carcinoma.
    Jarboe EA; Thompson LC; Heinz D; McGregor JA; Shroyer KR
    Hum Pathol; 2004 Apr; 35(4):396-402. PubMed ID: 15116318
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Role of p16, CK17, p63, and human papillomavirus in diagnosis of cervical intraepithelial neoplasia and distinction from its mimics.
    Selvi K; Badhe BA; Papa D; Ganesh RN
    Int J Surg Pathol; 2014 May; 22(3):221-30. PubMed ID: 23883975
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Diagnostic implications of L1, p16, and Ki-67 proteins and HPV DNA in low-grade cervical intraepithelial neoplasia.
    Gatta LB; Berenzi A; Balzarini P; Dessy E; Angiero F; Alessandri G; Gambino A; Grigolato P; Benetti A
    Int J Gynecol Pathol; 2011 Nov; 30(6):597-604. PubMed ID: 21979598
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Importance of immunohistochemical studies in the diagnosis and the prognostic evaluation of cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix. Review].
    García-Tamayo J; Molina J; Blasco-Olaetxea E
    Invest Clin; 2009 Jun; 50(2):241-50. PubMed ID: 19662819
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Extended duration of the detectable stage by adding HPV test in cervical cancer screening.
    van den Akker-van Marie ME; van Ballegooijen M; Rozendaal L; Meijer CJ; Habbema JD
    Br J Cancer; 2003 Nov; 89(10):1830-3. PubMed ID: 14612887
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Immunocytochemical colocalization of P16(INK4a) and Ki-67 predicts CIN2/3 and AIS/adenocarcinoma.
    Singh M; Mockler D; Akalin A; Burke S; Shroyer A; Shroyer KR
    Cancer Cytopathol; 2012 Feb; 120(1):26-34. PubMed ID: 22162342
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Usefulness of CINtec® PLUS p16/Ki-67 double-staining in cytological screening of cervical cancer.
    Yoshida T; Sano T; Kanuma T; Inoue H; Itoh T; Yazaki C; Obara M; Fukuda T
    Acta Cytol; 2011; 55(5):413-20. PubMed ID: 21986167
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.
    Ronco G; Giorgi-Rossi P; Carozzi F; Confortini M; Dalla Palma P; Del Mistro A; Gillio-Tos A; Minucci D; Naldoni C; Rizzolo R; Schincaglia P; Volante R; Zappa M; Zorzi M; Cuzick J; Segnan N;
    J Natl Cancer Inst; 2008 Apr; 100(7):492-501. PubMed ID: 18364502
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial.
    Ronco G; Segnan N; Giorgi-Rossi P; Zappa M; Casadei GP; Carozzi F; Dalla Palma P; Del Mistro A; Folicaldi S; Gillio-Tos A; Nardo G; Naldoni C; Schincaglia P; Zorzi M; Confortini M; Cuzick J;
    J Natl Cancer Inst; 2006 Jun; 98(11):765-74. PubMed ID: 16757701
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Triage of LSIL/ASC-US with p16/Ki-67 dual staining and human papillomavirus testing: a 2-year prospective study.
    White C; Bakhiet S; Bates M; Keegan H; Pilkington L; Ruttle C; Sharp L; O' Toole S; Fitzpatrick M; Flannelly G; O' Leary JJ; Martin CM
    Cytopathology; 2016 Aug; 27(4):269-76. PubMed ID: 26932360
    [TBL] [Abstract][Full Text] [Related]  

  • 91. p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis.
    Tsoumpou I; Arbyn M; Kyrgiou M; Wentzensen N; Koliopoulos G; Martin-Hirsch P; Malamou-Mitsi V; Paraskevaidis E
    Cancer Treat Rev; 2009 May; 35(3):210-20. PubMed ID: 19261387
    [TBL] [Abstract][Full Text] [Related]  

  • 92. p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women.
    Wentzensen N; Fetterman B; Castle PE; Schiffman M; Wood SN; Stiemerling E; Tokugawa D; Bodelon C; Poitras N; Lorey T; Kinney W
    J Natl Cancer Inst; 2015 Dec; 107(12):djv257. PubMed ID: 26376685
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women.
    Nobbenhuis MA; Helmerhorst TJ; van den Brule AJ; Rozendaal L; Jaspars LH; Voorhorst FJ; Verheijen RH; Meijer CJ
    J Clin Pathol; 2002 Jun; 55(6):435-9. PubMed ID: 12037026
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia.
    Schlecht NF; Kulaga S; Robitaille J; Ferreira S; Santos M; Miyamura RA; Duarte-Franco E; Rohan TE; Ferenczy A; Villa LL; Franco EL
    JAMA; 2001 Dec; 286(24):3106-14. PubMed ID: 11754676
    [TBL] [Abstract][Full Text] [Related]  

  • 95. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
    Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
    Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
    [TBL] [Abstract][Full Text] [Related]  

  • 96. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica.
    Schiffman M; Herrero R; Hildesheim A; Sherman ME; Bratti M; Wacholder S; Alfaro M; Hutchinson M; Morales J; Greenberg MD; Lorincz AT
    JAMA; 2000 Jan; 283(1):87-93. PubMed ID: 10632285
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Telomerase assay and HPV 16/18 typing as adjunct to conventional cytological cervical cancer screening.
    Ngan HY; Cheung AN; Liu SS; Liu KL; Tsao SW
    Tumour Biol; 2002; 23(2):87-92. PubMed ID: 12065846
    [TBL] [Abstract][Full Text] [Related]  

  • 98. HPV testing in primary screening of older women.
    Cuzick J; Beverley E; Ho L; Terry G; Sapper H; Mielzynska I; Lorincz A; Chan WK; Krausz T; Soutter P
    Br J Cancer; 1999 Oct; 81(3):554-8. PubMed ID: 10507785
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Beyond P16/Ki67 dual-stain cytology: Exploring alternative biomarkers for diagnosing cervical cancer and its precursors.
    Rauf SA; Zehra SA; Shah HH
    BJOG; 2024 Jan; 131(1):115-116. PubMed ID: 37345409
    [No Abstract]   [Full Text] [Related]  

  • 100. [Biopsy in the diagnosis of human papilloma virus in the context of a vaccine].
    Curiel-Valdés Jde J
    Cir Cir; 2008; 76(1):1-3. PubMed ID: 18492413
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.